Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 78.60
-2.10 (-2.60%)
Jun 25, 2026, 2:05 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 5.2 billion as of June 25, 2026. Its market cap has increased by 327.83% in one year.
Market Cap
5.20B
Enterprise Value
4.77B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
78.60
Market Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 5.20B, an increase of 132.01%. That is a compound annual growth rate of 44.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 5.20B | 29.78% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinphar Pharmaceutical | 6.14B |
| TaiGen Biopharmaceuticals Holdings | 6.02B |
| Savior Lifetec | 6.01B |
| AnnJi Pharmaceutical | 5.61B |
| TWi Biotechnology | 5.44B |
| Panion & Bf Biotech | 5.26B |
| Mycenax Biotech | 5.12B |
| UnicoCell Biomed | 5.02B |